Neuropathy and pain in Fabry disease
Authors:
- Vijay Krishna MedalaVMVijay Krishna Medala
- Nurcan ÜçeylerNÜNurcan Üçeyler
Open Access
- 8 July 2024
- journal article
- review article
- Published by OAE Publishing Inc. in Rare Disease and Orphan Drugs Journal
- Vol. 3 (3)
Abstract
Fabry disease (FD) is a multiorgan lysosomal storage disorder caused by mutations in the alfa-galactosidase A (GLA ) gene. Pathogenic GLA mutations lead to impaired or even lost enzyme activity, which causes the accumulation of sphingolipids, e.g., globotriaosylceramide, in cells and tissues. The majority of FD patients experience triggerable pain, mainly acral and burning, which often begins in early childhood. While small fiber pathology is assumed to be the basis of FD pain, the underlying molecular mechanisms are not well understood. This review summarizes the clinical characteristics of neuropathy and neuropathic pain in FD, presents current treatment options, and gives an overview of the latest findings from experimental and human model systems on the pathomechanisms contributing to small fiber pathology and FD-associated pain.Keywords
This publication has 101 references indexed in Scilit:
- Keratinocytes Communicate with Sensory Neurons via Synaptic‐like ContactsAnnals of Neurology, 2020
- Enhanced thrombospondin-1 causes dysfunction of vascular endothelial cells derived from Fabry disease-induced pluripotent stem cellsEBioMedicine, 2020
- Symptoms and Quality of Life in Patients with Fabry Disease: Results from an International Patient SurveyAdvances in Therapy, 2019
- Understanding nociception-related phenotypes in adult zebrafish: Behavioral and pharmacological characterization using a new acetic acid modelBehavioural Brain Research, 2019
- Pain relief in a neuropathy patient by lacosamide: Proof of principle of clinical translation from patient-specific iPS cell-derived nociceptorsEBioMedicine, 2019
- Impact of analgesic drugs on the behavioural responses of larval zebrafish to potentially noxious temperaturesApplied Animal Behaviour Science, 2017
- Upregulated TLR3 Promotes Neuropathic Pain by Regulating Autophagy in Rat With L5 Spinal Nerve Ligation ModelNeurochemical Research, 2016
- Expression of LC3 and Beclin 1 in the spinal dorsal horn following spinal nerve ligation-induced neuropathic painBrain Research, 2013
- Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry diseaseMuscle & Nerve, 2003
- Enzyme Replacement Therapy in Fabry DiseaseJAMA, 2001